Endocrinology Research and Practice
Case Report

Therapeutic Plasmapheresis in Amiodarone-Induced Thyrotoxicosis Resistant to Medical Therapy

1.

Kahramanmaraş Sütçü İmam University Faculty of Medicine, Department of Endocrinology and Metabolism, Kahramanmaraş, Turkey

2.

Kahramanmaraş Sütçü İmam University Faculty of Medicine, Department of Internal Medicine, Kahramanmaraş, Turkey

3.

Kahramanmaraş Sütçü İmam University Faculty of Medicine, Department of Nephrology, Kahramanmaraş, Turkey

4.

Kahramanmaraş Sütçü İmam University Faculty of Medicine, Department of General Surgery, Kahramanmaraş, Turkey

Endocrinol Res Pract 2019; 23: 253-258
DOI: 10.25179/tjem.2019-66735
Read: 2401 Downloads: 664 Published: 01 December 2019

ABSTRACT

Amiodarone treatment is associated with thyroid dysfunction resulting in life-threatening thyrotoxicosis. Thyroidectomy may be required if medication is contraindicated or thyroid dysfunction is resistant to the treatment. Therapeutic plasmapheresis (TP) may thus be considered to ensure perioperative euthyroidism, prevent thyroid storm and decrease the risk in surgery. In this case report, we discussed the potential option of TP treatment in the surgical preparation of a patient with Type 1 amiodarone-induced thyrotoxicosis resistant to antithyroid therapy.

 

 

Files
EISSN 2822-6135